Trait centric view

1. Trait name:	Feet and leg conformation
   Ontology terms:	VT:1000738

   199 genes are associated with this trait, with QTL/association found

   • ACOXL: Acyl-CoA oxidase like
     evidenced by: QTL:45061;
   • ADAMTS17: ADAM metallopeptidase with thrombospondin type 1 motif 17
     evidenced by: QTL:50971;
   • ADAMTS6: ADAM metallopeptidase with thrombospondin type 1 motif 6
     evidenced by: QTL:50596;
   • ADCY3: Adenylate cyclase 3
     evidenced by: QTL:45544; QTL:45558;
   • ALMS1: ALMS1 centrosome and basal body associated protein
     evidenced by: QTL:45128;
   • AMOT: Angiomotin
     evidenced by: QTL:54699;
   • ANKFN1: Ankyrin repeat and fibronectin type III domain containing 1
     evidenced by: QTL:50008;
   • ANKRD17: Ankyrin repeat domain 17
     evidenced by: QTL:42309;
   • APBB2: Amyloid beta precursor protein binding family B member 2
     evidenced by: QTL:42044;
   • APLF: Aprataxin and PNKP like factor
     evidenced by: QTL:45505;
   • ARHGAP10: Rho GTPase activating protein 10
     evidenced by: QTL:48695;
   • ARHGAP26: Rho GTPase activating protein 26
     evidenced by: QTL:43059;
   • ARHGAP6: Rho GTPase activating protein 6
     evidenced by: QTL:55455;
   • ARPIN: Actin related protein 2/3 complex inhibitor
     evidenced by: QTL:51111;
   • ATP1A3: ATPase Na+/K+ transporting subunit alpha 3
     evidenced by: QTL:49728;
   • BCAS3: BCAS3 microtubule associated cell migration factor
     evidenced by: QTL:50027;
   • BDP1: B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB
     evidenced by: QTL:50524;
   • BTBD11: BTB domain containing 11
     evidenced by: QTL:41133; QTL:41148;
   • C10H15ORF41: Chromosome 10 open reading frame, human C15orf41
     evidenced by: QTL:125869;
   • C18H19ORF47: Chromosome 18 C19orf47 homolog
     evidenced by: QTL:49663;
   • CADPS2: Calcium dependent secretion activator 2
     evidenced by: QTL:40621;
   • CAPN3: Calpain 3, (p94)
     evidenced by: QTL:44588;
   • CCDC69: Coiled-coil domain containing 69
     evidenced by: QTL:43215;
   • CCDC91: Coiled-coil domain containing 91
     evidenced by: QTL:41326;
   • CDH6: Cadherin 6
     evidenced by: QTL:50299;
   • CEP70: Centrosomal protein 70
     evidenced by: QTL:38824;
   • CERS5: Ceramide synthase 5
     evidenced by: QTL:40843;
   • CERS6: Ceramide synthase 6
     evidenced by: QTL:39103;
   • CFAP43: Cilia and flagella associated protein 43
     evidenced by: QTL:52827;
   • CHN2: Chimerin 2
     evidenced by: QTL:40451;
   • CHRM3: Cholinergic receptor muscarinic 3
     evidenced by: QTL:53718; QTL:53729;
   • CNTN5: Contactin 5
     evidenced by: QTL:47780;
   • COBLL1: Cordon-bleu WH2 repeat protein like 1
     evidenced by: QTL:39234;
   • COL12A1: Collagen type XII alpha 1 chain
     evidenced by: QTL:51958;
   • COL4A1: Collagen type IV alpha 1 chain
     evidenced by: QTL:46566;
   • COL4A4: Collagen type IV alpha 4 chain
     evidenced by: QTL:39572;
   • COL4A6: Collagen type IV alpha 6 chain
     evidenced by: QTL:54590;
   • CPAMD8: C3 and PZP like alpha-2-macroglobulin domain containing 8
     evidenced by: QTL:42677;
   • CPEB3: Cytoplasmic polyadenylation element binding protein 3
     evidenced by: QTL:52667;
   • CPQ: Carboxypeptidase Q
     evidenced by: QTL:47683;
   • CPSF3: Cleavage and polyadenylation specific factor 3
     evidenced by: QTL:46017;
   • CRTC1: CREB regulated transcription coactivator 1
     evidenced by: QTL:42637;
   • CUL2: Cullin 2
     evidenced by: QTL:46811;
   • CUL3: Cullin 3
     evidenced by: QTL:39541;
   • DACH1: Dachshund family transcription factor 1
     evidenced by: QTL:46323;
   • DHX32: DEAH-box helicase 32 (putative)
     evidenced by: QTL:53090;
   • DHX35: DEAH (Asp-Glu-Ala-His) box polypeptide 35
     evidenced by: QTL:28147;
   • DHX36: DEAH-box helicase 36
     evidenced by: QTL:38698;
   • DOCK1: Dedicator of cytokinesis 1
     evidenced by: QTL:53109;
   • DOT1L: DOT1 like histone lysine methyltransferase
     evidenced by: QTL:42851;
   • DTNB: Dystrobrevin beta
     evidenced by: QTL:45535;
   • EBF1: EBF transcription factor 1
     evidenced by: QTL:43245;
   • EGF: Epidermal growth factor
     evidenced by: QTL:41921;
   • EPB41L2: Erythrocyte membrane protein band 4.1 like 2
     evidenced by: QTL:44095;
   • FA2H: Fatty acid 2-hydroxylase
     evidenced by: QTL:49436;
   • FAS: Fas (TNF receptor superfamily, member 6)
     evidenced by: QTL:52653;
   • FAT3: FAT atypical cadherin 3
     evidenced by: QTL:53870; QTL:53887;
   • FBLN1: Fibulin 1
     evidenced by: QTL:41710;
   • FBLN5: Fibulin 5
     evidenced by: QTL:51387;
   • FGFR1: Fibroblast growth factor receptor 1
     evidenced by: QTL:125881;
   • FHIT: Fragile histidine triad diadenosine triphosphatase
     evidenced by: QTL:51689; QTL:51720;
   • FLNB: Filamin B
     evidenced by: QTL:125877;
   • FLT4: Fms related receptor tyrosine kinase 4
     evidenced by: QTL:42618;
   • FRMD5: FERM domain containing 5
     evidenced by: QTL:51342;
   • GABARAPL1: GABA(A) receptor-associated protein like 1
     evidenced by: QTL:41518;
   • GABRR3: Gamma-aminobutyric acid type A receptor rho3 subunit
     evidenced by: QTL:38364;
   • GALNT2: Polypeptide N-acetylgalactosaminyltransferase 2
     evidenced by: QTL:53646;
   • GANC: Glucosidase alpha, neutral C
     evidenced by: QTL:44574;
   • GARS1: Glycyl-tRNA synthetase 1
     evidenced by: QTL:40439;
   • GPM6B: Glycoprotein M6B
     evidenced by: QTL:55437;
   • GRB2: Growth factor receptor bound protein 2
     evidenced by: QTL:50139;
   • GRIA3: Glutamate ionotropic receptor AMPA type subunit 3
     evidenced by: QTL:54169; QTL:54185;
   • GRIK2: Glutamate ionotropic receptor kainate type subunit 2
     evidenced by: QTL:43996;
   • GSK3A: Glycogen synthase kinase 3 alpha
     evidenced by: QTL:49681;
   • GSTO2: Glutathione S-transferase omega 2
     evidenced by: QTL:52842;
   • HCRTR2: Hypocretin receptor 2
     evidenced by: QTL:51987;
   • HHAT: Hedgehog acyltransferase
     evidenced by: QTL:48482;
   • HPCAL1: Hippocalcin like 1
     evidenced by: QTL:45965; QTL:45974;
   • HSD17B12: Hydroxysteroid (17-beta) dehydrogenase 12
     evidenced by: QTL:47973;
   • HSD17B14: Hydroxysteroid 17-beta dehydrogenase 14
     evidenced by: QTL:49849;
   • ITGB1BP1: Integrin subunit beta 1 binding protein 1
     evidenced by: QTL:46028;
   • ITPK1: Inositol-tetrakisphosphate 1-kinase
     evidenced by: QTL:51419;
   • JAK1: Janus kinase 1
     evidenced by: QTL:39919; QTL:39939;
   • KCNIP1: Potassium voltage-gated channel interacting protein 1
     evidenced by: QTL:50353;
   • KCNIP4: Kv channel interacting protein 4
     evidenced by: QTL:41965;
   • KCTD2: Potassium channel tetramerization domain containing 2
     evidenced by: QTL:50150;
   • KDM6A: Lysine demethylase 6A
     evidenced by: QTL:54873;
   • KNG1: Kininogen 1
     evidenced by: QTL:125864; QTL:125865;
   • LETM1: Leucine zipper and EF-hand containing transmembrane protein 1
     evidenced by: QTL:42555;
   • LIN7A: Lin-7 homolog A, crumbs cell polarity complex component
     evidenced by: QTL:40736; QTL:40753;
   • LMO7: LIM domain 7
     evidenced by: QTL:46419;
   • LOC101905904: Uncharacterized LOC101905904
     evidenced by: QTL:28148;
   • LOC514011: Uncharacterized LOC514011
     evidenced by: QTL:125875;
   • MAGI1: Membrane associated guanylate kinase, WW and PDZ domain containing 1
     evidenced by: QTL:51645;
   • MCUB: Mitochondrial calcium uniporter dominant negative subunit beta
     evidenced by: QTL:41939;
   • MGMT: O-6-methylguanine-DNA methyltransferase
     evidenced by: QTL:53254;
   • MID1: Midline 1
     evidenced by: QTL:55495;
   • MRC2: Mannose receptor C type 2
     evidenced by: QTL:49982;
   • MSGN1: Mesogenin 1
     evidenced by: QTL:45664;
   • MSN: Moesin
     evidenced by: QTL:54824;
   • MYBPC1: Myosin binding protein C, slow type
     evidenced by: QTL:40982;
   • NBAS: NBAS subunit of NRZ tethering complex
     evidenced by: QTL:38377; QTL:45723; QTL:45740; QTL:45757;
   • NEDD4: Neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase
     evidenced by: QTL:125871;
   • NELFA: Negative elongation factor complex member A
     evidenced by: QTL:42593;
   • NFAM1: NFAT activating protein with ITAM motif 1
     evidenced by: QTL:41673;
   • NHS: NHS actin remodeling regulator
     evidenced by: QTL:55241;
   • NHSL1: NHS like 1
     evidenced by: QTL:44138;
   • NMUR1: Neuromedin U receptor 1
     evidenced by: QTL:39624;
   • NRG3: Neuregulin 3
     evidenced by: QTL:53802;
   • NRP1: Neuropilin 1
     evidenced by: QTL:46888;
   • NSD2: Nuclear receptor binding SET domain protein 2
     evidenced by: QTL:42574;
   • NT5DC3: 5'-nucleotidase domain containing 3
     evidenced by: QTL:41048;
   • NT5E: 5'-nucleotidase, ecto (CD73)
     evidenced by: QTL:44077;
   • NYAP2: Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2
     evidenced by: QTL:39557;
   • OAZ1: Ornithine decarboxylase antizyme 1
     evidenced by: QTL:42839;
   • OSBPL10: Oxysterol binding protein like 10
     evidenced by: QTL:51559;
   • OSR1: Odd-skipped related transcription factor 1
     evidenced by: QTL:45626;
   • OTOP3: Otopetrin 3
     evidenced by: QTL:50164;
   • PAH: Phenylalanine hydroxylase
     evidenced by: QTL:41014;
   • PAK5: P21 (RAC1) activated kinase 5
     evidenced by: QTL:46624;
   • PARD3: Par-3 family cell polarity regulator
     evidenced by: QTL:46825; QTL:46840; QTL:46856; QTL:46871;
   • PCBD1: Pterin-4 alpha-carbinolamine dehydratase 1
     evidenced by: QTL:53776;
   • PDE4D: Phosphodiesterase 4D
     evidenced by: QTL:50690; QTL:50709;
   • PDGFRB: Platelet derived growth factor receptor beta
     evidenced by: QTL:43176;
   • PER2: Period circadian regulator 2
     evidenced by: QTL:40307;
   • PHEX: Phosphate regulating endopeptidase homolog X-linked
     evidenced by: QTL:55152; QTL:55166;
   • PHKA2: Phosphorylase kinase regulatory subunit alpha 2
     evidenced by: QTL:55214;
   • PITRM1: Pitrilysin metallopeptidase 1
     evidenced by: QTL:47106;
   • PLCB1: Phospholipase C beta 1
     evidenced by: QTL:46608;
   • PLCH1: Phospholipase C eta 1
     evidenced by: QTL:38686;
   • PMP22: Peripheral myelin protein 22
     evidenced by: QTL:49965;
   • PPP1R14C: Protein phosphatase 1 regulatory inhibitor subunit 14C
     evidenced by: QTL:44243;
   • PRDM16: PR domain containing 16
     evidenced by: QTL:48310; QTL:48320; QTL:48331;
   • PRICKLE1: Prickle planar cell polarity protein 1
     evidenced by: QTL:40881;
   • PRKD1: Protein kinase D1
     evidenced by: QTL:51182; QTL:51195; QTL:51209;
   • PRLHR: Prolactin releasing hormone receptor
     evidenced by: QTL:52909;
   • PRRX2: Paired related homeobox 2
     evidenced by: QTL:46102;
   • RAB15: RAB15, member RAS oncogene family
     evidenced by: QTL:44928;
   • RAD54B: RAD54 homolog B
     evidenced by: QTL:47714;
   • RASA3: RAS p21 protein activator 3
     evidenced by: QTL:46577;
   • RBM47: RNA binding motif protein 47
     evidenced by: QTL:42033;
   • RBMS1: RNA binding motif single stranded interacting protein 1
     evidenced by: QTL:39371;
   • RCAN2: Regulator of calcineurin 2
     evidenced by: QTL:52126;
   • REN: Renin
     evidenced by: QTL:48039;
   • RFX4: Regulatory factor X4
     evidenced by: QTL:41095;
   • RNF157: Ring finger protein 157
     evidenced by: QTL:50083;
   • ROCK2: Rho associated coiled-coil containing protein kinase 2
     evidenced by: QTL:45917;
   • RPAP1: RNA polymerase II associated protein 1
     evidenced by: QTL:44536;
   • RSPO2: R-spondin 2
     evidenced by: QTL:47652;
   • SEC22A: SEC22 homolog A, vesicle trafficking protein
     evidenced by: QTL:38460;
   • SEC23IP: SEC23 interacting protein
     evidenced by: QTL:53008;
   • SEC24D: SEC24 homolog D, COPII coat complex component
     evidenced by: QTL:41847;
   • SEC63: SEC63 homolog, protein translocation regulator
     evidenced by: QTL:43962;
   • SERPINB5: Serpin family B member 5
     evidenced by: QTL:52453;
   • SFXN4: Sideroflexin 4
     evidenced by: QTL:52973;
   • SH2D2A: SH2 domain containing 2A
     evidenced by: QTL:39745;
   • SHROOM2: Shroom family member 2
     evidenced by: QTL:55630;
   • SLC25A12: Solute carrier family 25 member 12
     evidenced by: QTL:39078;
   • SLC25A13: Solute carrier family 25 member 13
     evidenced by: QTL:40333;
   • SLC25A21: Solute carrier family 25 member 21
     evidenced by: QTL:51283;
   • SLCO1A2: Solute carrier organic anion transporter family member 1A2
     evidenced by: QTL:41443;
   • SLIT3: Slit guidance ligand 3
     evidenced by: QTL:50312; QTL:50335;
   • SMARCA5: SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5
     evidenced by: QTL:48830;
   • SMYD1: SET and MYND domain containing 1
     evidenced by: QTL:45406;
   • SNX29: Sorting nexin 29
     evidenced by: QTL:52507;
   • SOWAHB: Sosondowah ankyrin repeat domain family member B
     evidenced by: QTL:42343; QTL:42357;
   • SPATA3: Spermatogenesis associated 3
     evidenced by: QTL:39603;
   • SPOCK1: SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1
     evidenced by: QTL:43007;
   • SPRED2: Sprouty related EVH1 domain containing 2
     evidenced by: QTL:45495;
   • SREBF2: Sterol regulatory element binding transcription factor 2
     evidenced by: QTL:41617;
   • SRGAP2: SLIT-ROBO Rho GTPase activating protein 2
     evidenced by: QTL:48101;
   • SRP68: Signal recognition particle 68
     evidenced by: QTL:50101;
   • SUN2: Sad1 and UNC84 domain containing 2
     evidenced by: QTL:41569;
   • SYN3: Synapsin III
     evidenced by: QTL:41181; QTL:41197; QTL:41219;
   • TANK: TRAF family member associated NFKB activator
     evidenced by: QTL:39340;
   • TASP1: Taspase 1
     evidenced by: QTL:46761;
   • TBC1D12: TBC1 domain family member 12
     evidenced by: QTL:52683;
   • TBC1D9: TBC1 domain family member 9
     evidenced by: QTL:48960;
   • TEN1: TEN1 subunit of CST complex
     evidenced by: QTL:50116;
   • TMEM87B: Transmembrane protein 87B
     evidenced by: QTL:45049;
   • TPCN1: Two pore segment channel 1
     evidenced by: QTL:49388;
   • TRAPPC9: Trafficking protein particle complex 9
     evidenced by: QTL:47468; QTL:47481;
   • TRIM10: Tripartite motif containing 10
     evidenced by: QTL:125879;
   • TRIM23: Tripartite motif containing 23
     evidenced by: QTL:50583;
   • TTYH2: Tweety family member 2
     evidenced by: QTL:50194;
   • UBE2E2: Ubiquitin conjugating enzyme E2 E2
     evidenced by: QTL:53604;
   • UBR1: Ubiquitin protein ligase E3 component n-recognin 1
     evidenced by: QTL:44618; QTL:44632;
   • UNC5D: Unc-5 netrin receptor D
     evidenced by: QTL:53510;
   • WASL: Wiskott-Aldrich syndrome like
     evidenced by: QTL:125868;
   • WDFY3: WD repeat and FYVE domain containing 3
     evidenced by: QTL:42478;
   • WWC3: WWC family member 3
     evidenced by: QTL:55573; QTL:55591;
   • XRCC4: X-ray repair cross complementing 4
     evidenced by: QTL:43324;
   • ZBTB39: Zinc finger and BTB domain containing 39
     evidenced by: QTL:40965;
   • ZFHX4: Zinc finger homeobox 4
     evidenced by: QTL:125874;
   • ZNF280D: Zinc finger protein 280D
     evidenced by: QTL:44778;
   • ZNF404: Zinc finger protein 404
     evidenced by: QTL:49775;
   • ZNF45: Zinc finger protein 45
     evidenced by: QTL:49792;
   • ZNF592: Zinc finger protein 592
     evidenced by: QTL:51136;
   • ZNF891: Zinc finger protein 891
     evidenced by: QTL:49227;
   100 correlations are found involving Feet and leg conformation